The potential prognostic and/or predictive value of cell cycle regulators (p27Kip1, p16INK4A, cyclin D1, cyclin D3, cyclin E, and Ki-67) has been evaluated in NSCLC patients who were enrolled in the IALT trial. Here, CDKN1B is linked to non-small cell lung carcinoma.